In this context, our study contributes to understanding the oncogenic role of miR-183-5p as an onco-miR, showing its ability to suppress TPM1, a tumor suppressor, and thereby promoting urothelial carcinogenesis. This evidence concerns the gene TPM1 and neoplasm.